1. Barone, P. W., Wiebe, M. E., Leung, J. C., Hussein, I., Keumurian, F. J., Bouressa, J., Brussel, A., Chen, D., Chong, M., Dehghani, H., & Gerentes, L. (2020). Viral contamination in biologic manufacture and implications for emerging therapies. Nature Biotechnology, 38(5), 563–572.
2. Drexler, H. G., & Uphoff, C. C. (2002). Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology, 39(2), 75–90.
3. Giuliano, C., Patel, C. R., & Kale-Pradhan, P. B. (2019). A guide to bacterial culture identification and results interpretation. Pharmacology & Therapeutics, 44(4), 192.
4. Knutsen, T. (1991). The ACT cytogenetic laboratory manual (2nd edn, pp. 563–587) (M. J. Barch, Ed.). Raven Press.
5. Lincoln, C. K., & Gabridge, M. G. (1998). Cell culture contamination: Sources, consequences, prevention, and elimination. Methods in Cell Biology, 57, 49–65.